Aura Biosciences (AURA) Other Non-Current Assets (2020 - 2026)
Aura Biosciences (AURA) reported Other Non-Current Assets of $517000.0 for Q1 2026, down 32.68% on a YoY basis from $768000.0 in Q1 2025, and up 9.77% quarter-over-quarter from $471000.0 in Q4 2025.
Aura Biosciences (AURA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Aura Biosciences has reported Other Non-Current Assets for 7 years, with the latest figure at $517000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 32.68% year-over-year to $517000.0; the trailing twelve-month figure through Mar 2026 stood at $517000.0 (down 32.68% YoY), and the FY2025 full-year result was $471000.0, down 9.07% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $517000.0, up from $471000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $893000.0 in Q2 2022, with the low at $125000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $612176.5 across 5 years, with a median of $768000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 614.4% — and 2025, when it plunged 75.91%.
- Aura Biosciences' Other Non-Current Assets stood at $768000.0 in 2022, then plunged by 33.72% to $509000.0 in 2023, then advanced by 1.77% to $518000.0 in 2024, then declined by 9.07% to $471000.0 in 2025, then increased by 9.77% to $517000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $517000.0 (Q1 2026), $471000.0 (Q4 2025), and $277000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - | 517,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 517,000.00 |
| Dec 31, 2025 | 471,000.00 |
| Sep 30, 2025 | 277,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 768,000.00 |
| Dec 31, 2024 | 518,000.00 |
| Sep 30, 2024 | 768,000.00 |
| Jun 30, 2024 | 768,000.00 |
| Mar 31, 2024 | 768,000.00 |
| Dec 31, 2023 | 509,000.00 |
| Sep 30, 2023 | 768,000.00 |
| Jun 30, 2023 | 768,000.00 |
| Mar 31, 2023 | 768,000.00 |
| Dec 31, 2022 | 768,000.00 |
| Sep 30, 2022 | 768,000.00 |
| Jun 30, 2022 | 893,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 125,000.00 |
| Jun 30, 2021 | 125,000.00 |